...
ntra-img

Natera Inc, Common Stock

NTRA

NSQ

$161.88

+$3.79

(2.4%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$20.49B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.81M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.53
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$58.53 L
$175.63 H
$161.88

About Natera Inc, Common Stock

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameNTRASectorS&P500
1-Week Return-2.8%-2.12%-3%
1-Month Return-3.57%-3.42%-0.73%
3-Month Return26.69%-11.13%2.87%
6-Month Return51.01%-5.74%7.17%
1-Year Return182.61%3.97%25.31%
3-Year Return75.98%1.05%28.38%
5-Year Return337.28%34.37%81.89%
10-Year Return611.87%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue302.33M391.00M625.49M820.22M1.08B[{"date":"2019-12-31","value":27.93,"profit":true},{"date":"2020-12-31","value":36.12,"profit":true},{"date":"2021-12-31","value":57.78,"profit":true},{"date":"2022-12-31","value":75.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue175.47M203.62M318.42M456.26M589.83M[{"date":"2019-12-31","value":29.75,"profit":true},{"date":"2020-12-31","value":34.52,"profit":true},{"date":"2021-12-31","value":53.98,"profit":true},{"date":"2022-12-31","value":77.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit126.86M187.38M307.07M363.97M492.74M[{"date":"2019-12-31","value":25.75,"profit":true},{"date":"2020-12-31","value":38.03,"profit":true},{"date":"2021-12-31","value":62.32,"profit":true},{"date":"2022-12-31","value":73.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin41.96%47.92%49.09%44.37%45.52%[{"date":"2019-12-31","value":85.47,"profit":true},{"date":"2020-12-31","value":97.62,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.39,"profit":true},{"date":"2023-12-31","value":92.71,"profit":true}]
Operating Expenses257.53M403.66M775.24M905.01M938.99M[{"date":"2019-12-31","value":27.43,"profit":true},{"date":"2020-12-31","value":42.99,"profit":true},{"date":"2021-12-31","value":82.56,"profit":true},{"date":"2022-12-31","value":96.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(130.68M)(216.28M)(468.17M)(541.04M)(446.25M)[{"date":"2019-12-31","value":-13067500000,"profit":false},{"date":"2020-12-31","value":-21627700000,"profit":false},{"date":"2021-12-31","value":-46817400000,"profit":false},{"date":"2022-12-31","value":-54104000000,"profit":false},{"date":"2023-12-31","value":-44624500000,"profit":false}]
Total Non-Operating Income/Expense1.31M(20.89M)(11.23M)(11.56M)23.43M[{"date":"2019-12-31","value":5.57,"profit":true},{"date":"2020-12-31","value":-89.15,"profit":false},{"date":"2021-12-31","value":-47.93,"profit":false},{"date":"2022-12-31","value":-49.35,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(122.83M)(229.65M)(471.10M)(546.82M)(434.53M)[{"date":"2019-12-31","value":-12282800000,"profit":false},{"date":"2020-12-31","value":-22964500000,"profit":false},{"date":"2021-12-31","value":-47109800000,"profit":false},{"date":"2022-12-31","value":-54682100000,"profit":false},{"date":"2023-12-31","value":-43453000000,"profit":false}]
Income Taxes2.00M98.00K618.00K978.00K271.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":4.9,"profit":true},{"date":"2021-12-31","value":30.92,"profit":true},{"date":"2022-12-31","value":48.92,"profit":true},{"date":"2023-12-31","value":13.56,"profit":true}]
Income After Taxes(124.83M)(229.74M)(471.72M)(547.80M)(434.80M)[{"date":"2019-12-31","value":-12482700000,"profit":false},{"date":"2020-12-31","value":-22974300000,"profit":false},{"date":"2021-12-31","value":-47171600000,"profit":false},{"date":"2022-12-31","value":-54779900000,"profit":false},{"date":"2023-12-31","value":-43480100000,"profit":false}]
Income From Continuous Operations(124.83M)(229.74M)(471.72M)(547.80M)(434.80M)[{"date":"2019-12-31","value":-12482700000,"profit":false},{"date":"2020-12-31","value":-22974300000,"profit":false},{"date":"2021-12-31","value":-47171600000,"profit":false},{"date":"2022-12-31","value":-54779900000,"profit":false},{"date":"2023-12-31","value":-43480100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(124.83M)(229.74M)(471.72M)(547.80M)(434.80M)[{"date":"2019-12-31","value":-12482700000,"profit":false},{"date":"2020-12-31","value":-22974300000,"profit":false},{"date":"2021-12-31","value":-47171600000,"profit":false},{"date":"2022-12-31","value":-54779900000,"profit":false},{"date":"2023-12-31","value":-43480100000,"profit":false}]
EPS (Diluted)(1.79)(2.77)(5.17)(5.57)(3.79)[{"date":"2019-12-31","value":-179,"profit":false},{"date":"2020-12-31","value":-277,"profit":false},{"date":"2021-12-31","value":-517,"profit":false},{"date":"2022-12-31","value":-557,"profit":false},{"date":"2023-12-31","value":-379,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NTRA
Cash Ratio 3.06
Current Ratio 4.39
Quick Ratio 4.23

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NTRA
ROA (LTM) -9.96%
ROE (LTM) -25.82%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NTRA
Debt Ratio Lower is generally better. Negative is bad. 0.45
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.55

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NTRA
Trailing PE NM
Forward PE NM
P/S (TTM) 13.62
P/B 23.76
Price/FCF 588
EV/R 13.33
EV/Ebitda NM
PEG NM

FAQs

What is Natera Inc share price today?

Natera Inc (NTRA) share price today is $161.88

Can Indians buy Natera Inc shares?

Yes, Indians can buy shares of Natera Inc (NTRA) on Vested. To buy Natera Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NTRA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Natera Inc be purchased?

Yes, you can purchase fractional shares of Natera Inc (NTRA) via the Vested app. You can start investing in Natera Inc (NTRA) with a minimum investment of $1.

How to invest in Natera Inc shares from India?

You can invest in shares of Natera Inc (NTRA) via Vested in three simple steps:

  • Click on Sign Up or Invest in NTRA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Natera Inc shares
What is Natera Inc 52-week high and low stock price?

The 52-week high price of Natera Inc (NTRA) is $175.63. The 52-week low price of Natera Inc (NTRA) is $58.53.

What is Natera Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Natera Inc (NTRA) is

What is Natera Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Natera Inc (NTRA) is 23.76

What is Natera Inc dividend yield?

The dividend yield of Natera Inc (NTRA) is 0.00%

What is the Market Cap of Natera Inc?

The market capitalization of Natera Inc (NTRA) is $20.49B

What is Natera Inc’s stock symbol?

The stock symbol (or ticker) of Natera Inc is NTRA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top